Model: NDC00075-0300-99

Theophylline Extended-release Ca

Special Features:

Anhydrous

Properties:

Active Medicament Medicinal Strength
300.000 milligrams theophylline active ingredient
Capsule Type
Any acceptable
Primary Container Type
Bottle
Capsule Content Form
Any acceptable
Capsule Primary Container Content Quantity
1000.000
Therapeutic Equivalent
Slo-bid by rorer pharmaceuticals
NSN
6505-01-172-1054
Part Number
NDC00075-0300-99
Description
Theophylline Extended-release Ca
CAGE
04518

Part NDC00075-0300-99 NSN 6505-01-172-1054

INC
FIIG
Concept No.
App. Key
Cond. Code
Status
INC:
42774
FIIG:
A510U0
Concept No.:
App. Key:
Cond. Code:
1
Status:
A

Material Classification

Hazardous material, precious metals, criticality, enviroment, and electrostatic discharge indicators
HMIC
PMIC
ESD/EMI
ENAC
MMAC
CRITL
HMIC:
P
PMIC:
A
ESD:
ESD:
MMAC:
CRITL:
X

Pricing & Availability Check

Submit this form for stock availability and pricing.
Part Number:
Quantity:
Email Address:
Phone Number:
Your Name:
Company:



Privacy Policy    Terms & Conditions

How to Order  

Ordering from buyaircraftparts.com

If you would like to order this theophylline extended-release ca (NSN 6505-01-172-1054) please submit the pricing and availability form above to receive an up to date quote by email. If you agree to the pricing and terms you can e-sign your order online!

We are pleased to have the opportunity to serve you.

Have a Question

Hours: 08:00-18:00 Eastern Standard Time
Phone: +1 470-231-0824
Email: Contact Form »
Schedule B and Export
  • Schedule B: 3004909185
  • SITC: 54293
  • End Use: Pharmaceutical preparations
  • NAICS: 325412
  • USDA: 1

Freight Class: Medicaments primarily affecting the eyes, ears or respiratory system, put up in measured doses or in forms or packings for retail sale, nesoi

Highest Rated Parts
Recently Purchased Parts
Hot Parts